可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Moeller HB,Knepper MA,Fenton RA.Serine 269 phosphorylated aquaporin-2 is targeted to the apical membrane of collecting duct principal cells[J].Kidney Int,2009,75(3):295-303.[2]Bouley R, Hawthorn G,Russo LM,et al.Aquaporin 2(AQP2)and vasopressin type 2 receptor (V2R) endocytosis in kidney epithelial cells:AQP2 is located in 'endocytosis-resistant' membrane domains after vasopressin treatment[J].Biol Cell,2006,98(4):215-232.[3]Morooka H,Iwanaga Y,Tamaki Y,et al.Chronic administration of oral vasopressin type 2 receptor antagonist tolvaptan exerts both myocardial and renal protective effects in rats with hypertensive heart failure[J].Circ Heart Fail,2012,5(4):484-492.[4]Bae EH,Ma SK.Water and sodium regulation in heart failure[J].Electrolyte Blood Press,2009,7(2):38-41.[5]Hunt SA,Abraham WT,China MH,et al.ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society[J].Circulation,2005,112(12):e154-e235.[6]卢武生,许顶立,殷晓燕,等.尿液水通道蛋白-2双抗体夹心ELISA测定法的建立[J].第一军医大学学报,2002,22(6):486-489.[7]卢武生,许顶立,孟素荣,等.充血性心力衰竭患者尿液水通道蛋白-2的临床检测[J].心脏杂志,2003,15(3):239-242.[8]Lu WS,Xu DL,Meng SR,et al.Change and significance of urinary excretion of aquaporin-2 defected by enzyme linked immunosorbent assay in rat models of heart failure[J].J Clin Rehabilitative Tissue Engineering Research,2007,11(25):5042-5043.[9]Nedvetsky PI,Tamma G,Beulshausen S,et al.Regulation of aquaporin-2 trafficking[J].Handb Exp Pharmacol,2009,(190):133-157.